Visit other SMART + STRONG sites:
POZREAL HEALTHTU SALUD
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
HIV Eradication: One Step Closer
Life Expectancy With HIV Increases Dramatically
Mouth Full of Problems: A Crisis in HIV Dental Care
New Technology Finds Meds That Might Flush Out Hidden HIV Reservoirs
New Hope for HIV Eradication
Personalized Therapeutic Vaccine Shows Promise
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

December 17, 2008

Tesamorelin Diminished Gut Fat in Phase 3 Study

The Canadian company Theratechnologies announced Monday that its experimental drug tesamorelin reduced belly fat accumulation by 18 percent over 52 weeks in the second of two Phase 3 clinical trials. And in a second announcement on Tuesday, the company confirmed a proposed deal with EMD Serono to sell the drug in the United States once it is approved.

Tesamorelin prompts the pituitary gland to release more growth hormone into the body and promotes fat loss.

The most recent Phase 3 clinical trial was similar in design to a previous study reported by the company. HIV-positive participants with gut-fat accumulation received either a placebo or tesamorelin for 26 weeks. At that point, people who had taken the placebo switched to tesamorelin and those who had taken the drug either stayed on it or switched to a placebo for an additional 26 weeks. After the first 26 week portion of the trial, people on tesamorelin lost 11 percent of their gut fat; those who remained on the drug for a full 52 weeks ultimately lost 18 percent. The drug appears not to interfere with the body’s development of insulin and control of blood sugar, a problem with EMD Serono’s Serostim (recombinant human growth hormone), another product studied to treat gut-fat accumulation in people with HIV.

In its deal with EMD Serono, Theratechnologies received a $30 million up-front payment. In return, EMD Serono will assist Theratechnologies with its application to the U.S. Food and Drug Administration for tesamorelin’s approval. Serono EMD will also sell the drug in the United States. Theratechnologies stands to gain as much as $215 million from the deal in addition to further royalties from future U.S. sales of the drug.

Search: Theratechnologies, tesamorelin, EMD Serono, lipodystrophy, fat accumulation, gut, Phase 3, growth hormone, Serostim


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 2 (of 2 total)    

George, , 2008-12-24 22:26:11
I have already made a comment, However, if you need someone to test this new drug on PLEASE consider contacting me. I would very much be willing to try. Thanks G

George D., , 2008-12-24 14:45:46
MAN, That sounds hopeful. I would give my SOUL to be able to loose some of this belly fat. I was always a slim kid/man when I was youger I was a professional male model. Then went on to develop a successful career in the fashion industry. Traveling and buying as well as training for as many as 40 or more large department stores. Took early retirement due to HIV health issues and now suffer from extreme depression. Due to the belly fat and what it does to me mentally! This could answer my prayers

comments 1 - 2 (of 2 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
My Cool Tools
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
Conference Coverage

CROI 2009
Montréal, Canada
February 8-11, 2009


48th Annual ICAAC/IDSA 46th Annual Meeting
Washington, DC
October 25-28, 2008


XVII International AIDS Conference
Mexico City, Mexico
August 3-8, 2008


more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2009 Smart + Strong. All Rights Reserved. Terms of use and Your privacy